Skip to content
MedsAcross

Medicine

Sodium iodide i-123 200 µCi capsule

Available on requestPrescription onlyUS FDAGeneric name

Sodium iodide i-123 200 µCi capsule is a generic prescription medicine for oral use, made by 2 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at controlled room temperature 20° to 25°C (68° to 77°F). Storage and…

Key facts

Active ingredient (INN)
Sodium iodide i-123
Brand
Sold under the generic name
Strength
200 µCi
Dosage form
Capsule
Route
Oral
Packs
1 bottle, 1 vial
Manufacturers
Cardinal HealthCurium
Origin register
US FDA, United States
Storage
Store at controlled room temperature 20° to 25°C (68° to 77°F). Storage and disposal of Sodium Iodide I 123 Capsules should be controlled in a manner that is in compliance with the appropriate regulations of the government agency authorized to license the use of this radionuclide.
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
2 January 2003
Identifiers
DailyMed set ID 493fa2ab-4eb0-4434-9739-3079b2f0e272, 50415c27-1928-4307-b1dc-648f47edf65dNDC 69945-602, 48815-1002Application ANDA071910, NDA018671

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
1 bottle in 1 can / 1 capsule, gelatin coated in 1 bottle69945-602-20Curium11 April 2007
1 vial, plastic in 1 can / 1 capsule, gelatin coated in 1 vial, plastic48815-1002-1Cardinal Health2 January 2003
1 vial, plastic in 1 can / 5 capsule, gelatin coated in 1 vial, plastic48815-1002-5Cardinal Health2 January 2003

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 24 March 1976Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Sodium iodide i-123

Clinical summary

Sodium iodide i-123 is a prescription medicine indicated as a diagnostic procedure to be used in evaluating thyroid function and/or morphology. It is available as capsules for oral use. MedsAcross supplies Sodium iodide i-123 for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Sodium iodide i-123

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Sodium iodide i-123 200 µCi capsule for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.